Literature DB >> 30236225

Centrifugal Surgery.

Maria Gaiser, Jochen Utikal.   

Abstract

Mesh：

Year:  2018        PMID： 30236225      PMCID： PMC6206251          DOI： 10.3238/arztebl.2018.0598a

Source DB:  PubMed          Journal:  Dtsch Arztebl Int        ISSN： 1866-0452            Impact factor:   5.594


× No keyword cloud information.
  4 in total

1.  Neoadjuvant imatinib in advanced primary or locally recurrent dermatofibrosarcoma protuberans: a multicenter phase II DeCOG trial with long-term follow-up.

Authors:  Selma Ugurel; Thomas Mentzel; Jochen Utikal; Peter Helmbold; Peter Mohr; Claudia Pföhler; Meinhard Schiller; Axel Hauschild; Rüdiger Hein; Eckhardt Kämpgen; Ivonne Kellner; Martin Leverkus; Jürgen C Becker; Philip Ströbel; Dirk Schadendorf
Journal:  Clin Cancer Res       Date:  2013-10-30       Impact factor: 12.531

2.  The Consequences of a "Harmless" Frontal Swelling.

Authors:  Florian J Kupilas; Johannes Kleinheinz; FirstName MiddleName LastName
Journal:  Dtsch Arztebl Int       Date:  2018-05-11       Impact factor: 5.594

3.  Molecular and clinical analysis of locally advanced dermatofibrosarcoma protuberans treated with imatinib: Imatinib Target Exploration Consortium Study B2225.

Authors:  Grant A McArthur; George D Demetri; Allan van Oosterom; Michael C Heinrich; Maria Debiec-Rychter; Christopher L Corless; Zariana Nikolova; Sasa Dimitrijevic; Jonathan A Fletcher
Journal:  J Clin Oncol       Date:  2005-02-01       Impact factor: 44.544

4.  Imatinib mesylate in advanced dermatofibrosarcoma protuberans: pooled analysis of two phase II clinical trials.

Authors:  Piotr Rutkowski; Martine Van Glabbeke; Cathryn J Rankin; Wlodzimierz Ruka; Brian P Rubin; Maria Debiec-Rychter; Alexander Lazar; Hans Gelderblom; Raf Sciot; Dolores Lopez-Terrada; Peter Hohenberger; Allan T van Oosterom; Scott M Schuetze
Journal:  J Clin Oncol       Date:  2010-03-01       Impact factor: 44.544
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.